CRE26-070: Refractory Hyperammonemic Encephalopathy as a Paraneoplastic Presentation of Fibrolamellar Hepatocellular Carcinoma: A Case Report
Journal of the National Comprehensive Cancer Network · 31.03.2026 · 24 (3.5)
DOI: 10.6004/jnccn.2025.7231 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of the National Comprehensive Cancer Network, erschienen am 31.03.2026. Verfasst von Harshitha Popuri und 6 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Internal Medicine, Texas Tech University Health Science Center, El Paso, TX.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- 1Department of Internal Medicine, Texas Tech University Health Science Center, El Paso, TX.
- 2Department of Pathology, Texas Tech University Health Science Center, El Paso, TX.
- 3Department of Hematology/Oncology, Texas Tech University Health Science Center, El Paso, TX.
Zitieren
APA
Popuri, H., Dey, R., Gulla, V., Chirrareddy, Y., Paritala, S., Bustamante, D., & Corral, J. (2026). CRE26-070: Refractory Hyperammonemic Encephalopathy as a Paraneoplastic Presentation of Fibrolamellar Hepatocellular Carcinoma: A Case Report. Journal of the National Comprehensive Cancer Network, 24(3.5). https://doi.org/10.6004/jnccn.2025.7231
Vancouver
Popuri H, Dey R, Gulla V, Chirrareddy Y, Paritala S, Bustamante D, et al. CRE26-070: Refractory Hyperammonemic Encephalopathy as a Paraneoplastic Presentation of Fibrolamellar Hepatocellular Carcinoma: A Case Report. Journal of the National Comprehensive Cancer Network. 2026;24(3.5). doi:10.6004/jnccn.2025.7231
BibTeX
@article{Popuri2026,
author = {Popuri, Harshitha and Dey, Ritwik and Gulla, Virali and Chirrareddy, Yagna and Paritala, Satyapriya and Bustamante, Daniel and Corral, Javier},
title = {CRE26-070: Refractory Hyperammonemic Encephalopathy as a Paraneoplastic Presentation of Fibrolamellar Hepatocellular Carcinoma: A Case Report},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2026},
volume = {24},
number = {3.5},
doi = {10.6004/jnccn.2025.7231}
}
EUVIMED